Here, new overseas drugs are allowed to be tested in China first, supported by multiple policies, and global companies are sincerely invited to join us in promoting the development of the bio-health industry.

Website: http://www.bdhxq.gov.cn

Beidaihe Life and Health Industry Innovation Zone is the first life and health industry innovation zone approved by the State Council and is committed to the development of the life and health industry. Beidaihe Life and Health Industry Innovation Zone covers an area of 520 square kilometers, of which the core area is 40 square kilometers, called Beidaihe New District. The climate here is suitable, with an average temperature of 23°C in midsummer, which is conducive to developing life sciences.

Listed as Zhongguancun's cross-border biopharmaceutical base, Beidaihe Life Health Industrial Innovation Area enjoys policies similar to Zhongguancun, offering advantages in innovative drug approval, cross-regional drug production pilots, and technological service taxation. Companies benefit from a 15% corporate income tax rate, streamlined clinical trial approval systems, and incentives for groundbreaking projects.

With 13 national-level and 25 provincial-level innovation support policies, Beidaihe New District actively collaborates with national departments for pilot policies. The "7+6" policy, issued by nine ministries, injects fresh momentum into the life and health industry, propelling it toward unprecedented growth.

Beidaihe New District has attracted prestigious institutions like Beijing University of Chinese Medicine Oriental Hospital Qinhuangdao and Tianjin Cancer Hospital Qinhuangdao, while top companies like Sanofi Group and Sinopharm Group have invested billions.

Panasi International Hospital, the first foreign-funded hospital in Hebei, stands as a testament to Beidaihe's commitment to health innovation. With advanced German medical standards and key technologies, Panasi pioneers a new era in health management, chronic disease management, and precision medicine.

Embrace the success story of South Korea's JK Medical Group, which signed a cooperation framework agreement with Beidaihe New District. Leveraging Beidaihe's policy advantages, JK Medical Group will introduce world-class medical and aesthetic technologies for cell regeneration and anti-aging projects.

Boasting rich educational resources, Qinhuangdao is home to universities like Yanshan University and Northeastern University Qinhuangdao Branch. With over 200,000 students and nearly 5,000 bioengineering graduates annually, Beidaihe provides a talent pool to drive your enterprise forward.

Join us in the Beidaihe Life and Health Industry Innovation Demonstration Zone – your gateway to a thriving ecosystem of health and innovation. Seize the opportunity to be part of a dynamic community committed to shaping the future of life and health.